Pharmaceutical

glp-1-receptor-agonists-in-ada-2024

Others

Next-gen GLP-1 Breakthroughs: Revolutionizing Diabetes and Obesity Treatment at ADA 2024

Explore More...
Pharma News Merck, AstraZeneca, and GSK

Merck’s Sotatercept Trial Result; PARP Rivals Closing in on AstraZeneca and Merck’s Lynparza; FDA Clears GSK’s Boostrix for Pertussis; Fast Track Designation to Nanoscope Therapeutics’s MCO-010; FDA Awards Fast Track Designation to Eftilagimod Alpha Plus Pembrolizumab; Solid Biosciences to Acquire AavantiBio

pcsk9-inhibitors-for-cholesterol-management

PCSK9 Inhibitors: A New Era for Cholesterol Management

peripheral-t-cell-lymphoma-treatment-market

Peripheral T-cell Lymphoma Treatment Market: How are Pipeline Therapies Reshaping the Therapeutic Outlook?

Pharma News for Zealand Pharma, Amylyx, Sarepta

Zealand Pharma’s Phase III Results of Glepaglutide; FDA Approves Amylyx’s ALS Drug Relyvrio; Novo Nordisk and Ventus Therapeutics Signs Licencing Deal; FDA Approves Futibatinib; Sarepta Files Duchenne Muscular Dystrophy for FDA Approval; Biogen and Eisai’s Lcanemab Phase III Study

Cutaneous T-cell Lymphoma Treatment Outlook

Insights Into The Cutaneous T-cell Lymphoma Treatment Market

Pharma News for Sangamo, Santen, and Eli Lilly

Daiichi Sankyo’s Ezharmia; Pfizer & Sangamo Hemophilia A Gene Therapy Trial; Approval for Fennec’s Pedmark; FDA Approves UBE and Santen’s OMLONTI; EC Approves AstraZeneca’s Tezspire; FDA Approves Selpercatinib; FDA Grants Accelerated Approval to Eli Lilly’s Retevmo; GSK & Spero Announce Exclusive License Agreement

PDE4-B Inhibitors: A Promising Target for Idiopathic Pulmonary Fibrosis Treatment

Pharma News and Updates for Akero Chiesi Pfizer

AstraZeneca’s Danicopan Trial; CHMP Recommends Sanofi/AstraZeneca’s nirsevimab; Akero’s NASH Drug Trial; FDA Grants Orphan Drug Status to SY-5609; BMS’s Opdivo Trial Results; Pfizer to File for FDA Approval for Meningitis Vaccine; EMA Orphan Drug Designation to CAN-2409; FDA Starts Priority Review of Chiesi ‘s velmanase alfa

Alcohol Use Disorder Treatment Market Outlook

Adial’s Micro-formulation: Opening New Massive Alcohol Use Disorder Treatment Market Opportunities

focal-segmental-glomerulosclerosis-market-outlook

Focal Segmental Glomerulosclerosis Market: Unfolding Insights into the Future

Pharma News for Amgen BioNTech and Gilead

Amgen Announced the Result of its CodeBreak-200 Trial; FDA Clears Bristol-Myers Squibb’s Deucravacitinib; BioNTech’s Amplified CAR-T Therapy; TIL Therapy Improves on Yervoy in Melanoma; GSK’s Daprodustat will have to face FDA Advisory Committee; Breakthrough Therapy Status to Pfizer’s Group B Strep Vaccine; EU Approves Gilead’ Tecartus; Gilead’ Trodelvy Results in TROPiCs-02 Trial

severe-asthma-treatment-scenario

How Emerging Pipeline Therapies Will Unfold the Severe Asthma Treatment Market Dynamics?

Pancreatic Cancer Therapeutics Market Outlook

Treatment to Clinical Development – A Bumpy Journey for Pancreatic Cancer

promising-alopecia-areata-treatment-options

Alopecia Areata Treatment: Which Pipeline Therapy Will Steal the Spotlight?

Pharma News for Azurity, Sobi, and Sanofi

AstraZeneca’s Imfinzi for Biliary Tract Cancer; FDA Clears Boehringer’s Spesolimab; Novo Nordisk to Acquire Forma Therapeutics; Sanofi’s Xenpozyme Approved for ASMD; Another FDA Approval to Azurity’s Konvomep; Amgen’s Lumakras Trial Results; FDA Grants Priority Review to Sanofi & Sobi’s efanesoctocog alfa; Neurocrine Bio to Takeover UK Biotech Diurnal

WHIM Syndrome Treatment Market

Which Pipeline Therapy Will Change the WHIM Syndrome Treatment Market Scenario?

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader